Pharmaceuticals Market Reports

Kalorama Information is your trusted source for market research on the pharmaceutical industry. Reports provide key trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with pharmaceutical industry leaders to provide accurate market assessments while personally researching the market to offer keen insights into consumer and institutional trends.

<< back 1 2 3 4 5 6 7 8 9 10 next >>

Title	Published	Price
World Market for Prescription Generic Drugs, 6th Edition Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to  |  more... Search inside this report	Apr 1, 2008	$3,995.00
Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market) Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a strategic planning, business  |  more... Search inside this report	Mar 15, 2008	$6,995.00
The Worldwide Market for Cancer Diagnostics, 3rd Edition Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics , the use of multiplex assays and  |  more...	Mar 1, 2008	$3,995.00
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the  |  more...	Mar 1, 2008	$3,995.00
RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector. Full coverage of the market for RFID technologies  |  more...	Mar 1, 2008	$1,995.00
Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets) Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy,  |  more...	Feb 1, 2008	$3,495.00
Pharmaceutical Excipients for Oral Formulations, 2nd. Edition Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well.  |  more... Search inside this report	Feb 1, 2008	$3,995.00
Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over. The United States Medicare system pays out more for the care of congestive heart failure than it does for all forms of  |  more... Search inside this report	Feb 1, 2008	$3,495.00
Pediatric Drugs: the Worldwide Market, 3rd Edition Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the rights of children to have access to safe and effective  |  more...	Jan 1, 2008	$3,995.00
Gene Expression Profiling Markets Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products—microarrays and RT-PCR—continue to gain widespread acceptance and to see revenues grow rapidly. However, different products and applications are increasingly being introduced,  |  more... Search inside this report	Jan 1, 2008	$3,995.00
Prescription Dermatological Drugs: Worldwide Market, 6th Edition One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the  |  more... Search inside this report	Jan 1, 2008	$4,200.00
Organ Transplant Immunosuppressive Markets Improved surgical techniques and organ preservation, understanding of immunologic barriers, and the development of newer and more potent immunosuppressives have combined to improve survival of transplant patients and grafts. Rejection remains the major barrier to long-term graft survival in patients, organ transplantation therapy is highly dependent on the success of  |  more... Search inside this report	Jan 1, 2008	$3,500.00
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets ) Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing  |  more... Search inside this report	Jan 1, 2008	$3,500.00
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents) Kalorama's 2nd edition of The World Cardiovascular Drugs Market , in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. Analyst Mary  |  more... Search inside this report	Dec 1, 2007	$3,995.00
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis.  |  more...	Nov 1, 2007	$3,995.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.) Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab  |  more...	Nov 1, 2007	$3,500.00
Prescribing Pharmacists: A Decision Maker Emerges In five years, Kalorama Information believes that given the role of pharmacists currently and the demands of the US healthcare system, pharmacists will be prescribing in at least six states in five years, creating a trend that will spread to many other states in following years. The state of  |  more... Search inside this report	Oct 1, 2007	$2,500.00
Drug Pricing and Reimbursement Strategies: Preparing for the Coming Generic Onslaught It can be said that pharmaceutical companies face a 'new era.' in the coming years. Old strategies will not produce the same results. A wave of generic competition is poised to affect most brands. Drug companies have had to cut research budgets, leading to a dearth  |  more... Search inside this report	Oct 1, 2007	$2,395.00
Retail Clinics, The Emerging Market for Convenience and In-Store Healthcare Retail clinics, also known as convenience clinics, represent a disruptive innovation into the U.S. health care market, which evolved from and is uniquely positioned to benefit from the health care system’s shortcomings. These clinics present a new opportunity for retail outlets to earn more revenue from rents and  |  more... Search inside this report	Oct 1, 2007	$2,995.00
Virtual Reality in U.S. Healthcare (Markets for Remote Surgery, 3D Modeling, Pain Distraction and Other Applications) The use of virtual reality (VR) technologies in the healthcare field is not simply a far-away future possibility. Technologies are already in place and the benefits from the application of VR are already evident in the healthcare domain. These applications provide doctors an opportunity to perform tasks in a  |  more...	Aug 1, 2007	$3,995.00
Global Hepatitis Treatment and Diagnostics The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles. In his exhaustive analysis of the potential diagnosis, screening and  |  more...	Aug 1, 2007	$3,995.00
Clinical Nutrition Products: World Market, 2nd. Edition The application of nutritional knowledge is an increasingly important part of the management and treatment of disease. Demographics and product development are expected to drive growth in the market for clinical nutrition. This Kalorama Information report - Clinical Nutrition Products: The World Market , represents the second time that Kalorama Information  |  more... Search inside this report	Aug 1, 2007	$3,495.00
Anesthesia Drugs: Worldwide Markets An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure  |  more... Search inside this report	Jul 1, 2007	$2,995.00
Global Tuberculosis Diagnostics and Treatment Markets The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles. As illustrated by Kenneth G.  |  more... Search inside this report	Jun 1, 2007	$3,995.00
Early Toxicology: Markets and Approaches Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient  |  more...	Jun 1, 2007	$3,495.00
Title	Published	Price

<< back 1 2 3 4 5 6 7 8 9 10 next >>